Hermann Medizintechnik ("Hermann") has officially joined Gilde Healthcare's group of contract manufacturers for complex surgical instruments and implants ("SPI"), marking another significant milestone for SPI. With Hermann, SPI grows to...
Gilde Healthcare company Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
Amphista to initiate its first clinical trial for AMX-883, a potent, orally bioavailable DCAF16-dependent degrader of BRD9, for acute myeloid leukaemia (AML) in H2 2026 The Phase 1 monotherapy dose-escalation...
June 11, 2026
Hermann Medizintechnik joins SPI – the specialized MedTech CDMO platform sponsored by Gilde Healthcare
Hermann Medizintechnik ("Hermann") has officially joined Gilde Healthcare's group of contract manufacturers for complex surgical instruments and implants ("SPI"), marking another significant milestone for SPI. With Hermann, SPI grows to...
September 10, 2026
Gilde Healthcare launches Climate Solutions fund realizing initial close at €250M
With commitments from international pension funds, banks, fund-of-funds, endowments and family offices, Gilde Healthcare realizes an initial close at €250 million Expansion into Climate Solutions builds on Gilde Healthcare’s track...
February 18, 2026
Hermann Medizintechnik joins SPI – the specialized MedTech CDMO platform sponsored by Gilde Healthcare
Hermann Medizintechnik ("Hermann") has officially joined Gilde Healthcare's group of contract manufacturers for complex surgical instruments and implants ("SPI"), marking another significant milestone for SPI. With Hermann, SPI grows to...
September 10, 2026
Filter & search
Fund strategy:
Loading...
These were all articles
ecb852a3f7